Cargando…

Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Hypertension

BACKGROUND: Pulmonary hypertension (PH) is associated with progressive impairment of right ventricular function, reduced exercise capacity and a poor prognosis. Little is known about the prevalence, clinical manifestation and impact of atrial fibrillation (AF) on cardiac function in PH. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rottlaender, Dennis, Motloch, Lukas J., Schmidt, Daniela, Reda, Sara, Larbig, Robert, Wolny, Martin, Dumitrescu, Daniel, Rosenkranz, Stephan, Erdmann, Erland, Hoppe, Uta C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306317/ https://www.ncbi.nlm.nih.gov/pubmed/22439013 http://dx.doi.org/10.1371/journal.pone.0033902

Ejemplares similares

UCP2 Modulates Cardioprotective Effects of Ru360 in Isolated Cardiomyocytes during Ischemia
por: Motloch, Lukas J., et al.
Publicado: (2015)

By Regulating Mitochondrial Ca(2+)-Uptake UCP2 Modulates Intracellular Ca(2+)
por: Motloch, Lukas Jaroslaw, et al.
Publicado: (2016)

UCP3 Regulates Single-Channel Activity of the Cardiac mCa1
por: Motloch, Lukas J., et al.
Publicado: (2016)

Beta(1)-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation
por: Nia, Amir M., et al.
Publicado: (2010)

Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy
por: Paar, Vera, et al.
Publicado: (2019)

Systemische Hantavirus-Infektion bei einem komatösen HIV Patienten
por: Larbig, Robert, et al.
Publicado: (2013)

Management of Implantable Cardioverter-Defibrillators during Pregnancy—A Systematic Review
por: Topf, Albert, et al.
Publicado: (2021)

Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study
por: Boxhammer, Elke, et al.
Publicado: (2023)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Impact of Rescue-Thrombolysis during Cardiopulmonary Resuscitation in Patients with Pulmonary Embolism
por: Er, Fikret, et al.
Publicado: (2009)

Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy
por: Havranek, Stepan, et al.
Publicado: (2020)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
por: Demirel, Ozan, et al.
Publicado: (2023)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

Correction to: The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenation
por: Hohmann, Christopher, et al.
Publicado: (2019)

Predictors of pulmonary hypertension after atrial septal defect closure: Impact of atrial fibrillation
por: Çelik, Mehmet, et al.
Publicado: (2022)

Case report: Subjective loss of performance after pulmonary embolism in an athlete– beyond normal values
por: Dumitrescu, Daniel, et al.
Publicado: (2016)

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study
por: Kramer, Tilmann, et al.
Publicado: (2021)

Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study
por: Havranek, Stepan, et al.
Publicado: (2023)

Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomised study
por: Havranek, S, et al.
Publicado: (2023)

Pulmonary vein remodeling in hypertension: Mechanistic insight into primary prevention of atrial fibrillation
por: Iwasaki, Yu-ki
Publicado: (2018)

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
por: Fiedler, Lukas, et al.
Publicado: (2023)

Visit-to-Visit Blood Pressure Variability Predicts Atrial Fibrillation Recurrence After Pulmonary Vein Isolation in Patients With Hypertension and Atrial Fibrillation
por: Kamioka, Masashi, et al.
Publicado: (2021)

Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study
por: Gerhardt, Felix, et al.
Publicado: (2017)

Atrial Fibrillation in Hypertension: Patients’ Characteristics
por: Koutsaki, Styliani, et al.
Publicado: (2018)

Right heart catheterisation: best practice and pitfalls in pulmonary hypertension
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2021)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
por: Mendys, Phil, et al.
Publicado: (2021)

Impact of pulmonary hypertension in patients undergoing atrial fibrillation ablation: A nationwide study
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019)

Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study
por: Lange, Philipp S., et al.
Publicado: (2021)

Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis
por: Jirak, Peter, et al.
Publicado: (2022)

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
por: Paar, Vera, et al.
Publicado: (2020)

Case report: Short-long-short mechanism triggering sustained ventricular tachycardia in a patient with a single-chamber ICD but inhibiting antitachycardia therapy
por: Schernthaner, Christiana, et al.
Publicado: (2022)

Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation
por: Gottlieb, Lisa A., et al.
Publicado: (2023)

Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe Pneumonia
por: Jirak, Peter, et al.
Publicado: (2021)

Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
por: Jirak, Peter, et al.
Publicado: (2022)

Diabetes, Hypertension, Atrial Fibrillation and Subsequent Stroke-Shift towards Young Ages in Brunei Darussalam
por: Bassa, Burc, et al.
Publicado: (2022)

Disturbed Left Atrial Function is Associated with Paroxysmal Atrial Fibrillation in Hypertension
por: Tenekecioglu, Erhan, et al.
Publicado: (2014)

Localized Pulmonary Vein Scar Promotes Atrial Fibrillation in High Left Atrial Pressure
por: Gottlieb, Lisa A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lr0vrljr47es54s0a3ehrvuogq